As clinical guidelines for cancer prevention refer individuals to primary care physicians (PCPs) for risk assessment and clinical management, PCPs may be expected to play an increasing role in cancer prevention. It is crucial that PCPs are adequately supported to assess an individual's cancer risk and make appropriate recommendations. The objective of this study is to assess use, familiarity, attitude and behaviors of PCPs regarding breast and ovarian cancer risk and prevention, to better understand the factors that influence their prescribing behaviors. We conducted a cross-sectional, web-based survey of PCPs in the United States, recruited from an opt-in healthcare provider panel. Invitations were sent in batches until the target sample size of 750 respondents (250 each for OB/GYN, internal medicine and family medicine) was met. Self-reported use of breast/ovarian cancer risk assessments was low (34.7%-59.2%) compared with discussion of cancer family history (96.9%), breast exams (87.1%) and mammograms (92.8%). While most respondents (48.0-66.8%) were familiar with cancer prevention interventions, respondents who reported to be less familiar were more likely to report cautious attitudes. When presented with hypothetical cases depicting patients at different breast/ovarian cancer risks, up to 34.0% of respondents did not select any of the clinically recommended course(s) of action. This survey suggests that PCP use of breast/ovarian cancer risk assessment tools and ability to translate the perceived risks to clinical actions is variable. Improving implementation of cancer risk assessment and clinical management guidelines within primary care may be necessary to improve the appropriate prescribing of cancer prevention interventions.

中文翻译：

---

乳腺癌或卵巢癌高危女性的评估和干预：初级保健医生调查

由于癌症预防的临床指南将个人转介给初级保健医师 (PCP) 进行风险评估和临床管理，因此预计 PCP 在癌症预防中将发挥越来越大的作用。至关重要的是，要充分支持 PCP 评估个人的癌症风险并提出适当的建议。本研究的目的是评估 PCP 在乳腺癌和卵巢癌风险和预防方面的使用、熟悉程度、态度和行为，以更好地了解影响其处方行为的因素。我们对美国的 PCP 进行了一项基于网络的横断面调查，该调查是从一个选择加入的医疗保健提供者小组中招募的。邀请分批发送，直到满足 750 名受访者的目标样本量（妇产科、内科和家庭医学各 250 名）。与讨论癌症家族史 (96.9%)、乳房检查 (87.1%) 和乳房 X 线照片 (92.8%) 相比，自我报告的乳腺癌/卵巢癌风险评估使用率较低 (34.7%-59.2%)。虽然大多数受访者 (48.0-66.8%) 熟悉癌症预防干预措施，但报告不太熟悉的受访者更有可能表示谨慎态度。当呈现描述具有不同乳腺癌/卵巢癌风险的患者的假设病例时，高达 34.0% 的受访者没有选择任何临床推荐的行动方案。该调查表明，PCP 对乳腺癌/卵巢癌风险评估工具的使用以及将感知风险转化为临床行动的能力是可变的。